US Patent 8357398 Benzonatate compositions and methods of use
Patent 8357398 was granted and assigned to Alitair Pharmaceuticals on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+114 characters)
Article
Patent abstract
Oral dosage forms of benzonatate useful for anti-tussive and anti-tussive/combination applications.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Doreen Marie Frank0
Russell Francis Somma0
William Wayne Howard0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08357398 Benzonatate compositions and methods of use US Patent 8357398 Benzonatate compositions and methods of use
Infobox
Patent Number
083573980
Patent Number
83573980
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083573980
Date of Patent
January 22, 2013
0Patent Application Number
129253530
Date Filed
October 20, 2010
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08357398 Benzonatate compositions and methods of use
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08357398
Date of patent
January 22, 2013
Patent application number
12925353
Date Filed
October 20, 2010
Patent primary examiner
Find more entities like US Patent 8357398 Benzonatate compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
